Skip to content

Studying the effect of motivational spirometry and diaphragmatic breathing on arterial blood oxygen saturation.

Studying the effect of motivational spirometry and diaphragmatic breathing on arterial blood oxygen saturation in patients with COVID hospitalized

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20251118068029N1
Enrollment
80
Registered
2025-11-20
Start date
2025-11-22
Completion date
Unknown
Last updated
2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronavirus disease (COVID-19)Respiratory hypoxia in patients with COVID-19 (with up to 50% lung involvement and no need for invasive ventilation). Coronavirus as the cause of diseases classified to other chapters

Interventions

Intervention 1: Control group: Diaphragmatic breathing: The patient, in a sitting or semi-sitting position, places one hand on the chest and the other on the abdomen. Deep breathing is performed throu

Sponsors

Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Conscious and cooperative individuals Having a definite diagnosis of COVID-19 Maximum 50% lung involvement Requiring a physician’s order for respiratory physiotherapy Systolic and diastolic blood pressure ranged 100-140 mmHg and 60-90 mmHg, respectively Heart rate range of 60-100 beats per minute

Exclusion criteria

Exclusion criteria: Suffering from COPD or bronchospasm (based on medical reports confirmed by a specialist) Being under the prescription of drugs that control vital signs (e.g., dopamine, dobutamine, nitroglycerin) Need of invasive ventilation

Design outcomes

Primary

MeasureTime frame
Changes in arterial oxygen saturation (SpO2) measured with a calibrated pulse oximeter at four times: before the intervention, immediately after the intervention, 5 minutes after the intervention, and 10 minutes after the intervention. Timepoint: Time points for measuring the main outcome (SpO2 and other vital signs):Before the intervention (Baseline)Immediately after the end of the intervention5 minutes after the end of the intervention10 minutes after the end of the intervention. Method of measurement: The percentage of arterial oxygen saturation (SpO2) will be measured non-invasively from the index or middle finger of the patient's non-dominant hand using a Saadat digital pulse oximeter device that has been calibrated and validated by the hospital's medical engineers. The measurement will be performed at four time points (before the intervention, immediately after, 5 minutes after, and 10 minutes after the intervention) and under the same conditions (sitting/semi-sitting position and complete patient rest), and the values ??will be recorded directly from the ward's central monitor and pulse oximeter.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAli Karimirozveh

Tehran University of Medical Sciences

karimi_rozveh@yahoo.com+98 21 6692 7171

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026